TAMIR BIOTECHNOLOGY, INC. (ACEL) financial statements (2020 and earlier)

Company profile

Business Address 300 ATRIUM DRIVE
SOMERSET, NJ 08873
State of Incorp. DE
Fiscal Year End July 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

7/31/2012
7/31/2011
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments0
Cash and cash equivalents0
Prepaid expense and other current assets0
Other undisclosed current assets0
Total current assets:0
Noncurrent Assets
Property, plant and equipment0
Deferred costs0
Total noncurrent assets:0
TOTAL ASSETS:0
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1
Accounts payable1
Accrued liabilities0
Debt3
Derivative instruments and hedges, liabilities1
Other undisclosed current liabilities0
Total current liabilities:5
Noncurrent Liabilities
Liabilities, other than long-term debt0
Accounts payable and accrued liabilities0
Other undisclosed noncurrent liabilities0
Total noncurrent liabilities:1
Total liabilities:6
Stockholders' equity
Stockholders' equity attributable to parent(6)
Common stock0
Additional paid in capital101
Accumulated deficit(107)
Total stockholders' equity:(6)
TOTAL LIABILITIES AND EQUITY:0

Income statement (P&L) ($ in millions)

7/31/2012
7/31/2011
Gross profit:1
Operating expenses(1)
Operating loss:(0)
Nonoperating expense
(Investment Income, Nonoperating)
(3)
Interest and debt expense(0)
Net loss:(3)
Other undisclosed net income attributable to parent5
Net income available to common stockholders, diluted:2

Comprehensive Income ($ in millions)

7/31/2012
7/31/2011
Net loss:(3)
Comprehensive loss, net of tax, attributable to parent:(3)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: